A Feasibility Study for Testing the Effects of Extended-release Naltrexone (Vivitrol) on Recidivism and Other Participant Outcomes in Drug Court Settings

Trial Profile

A Feasibility Study for Testing the Effects of Extended-release Naltrexone (Vivitrol) on Recidivism and Other Participant Outcomes in Drug Court Settings

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 May 2017

At a glance

  • Drugs Naltrexone (Primary) ; Naltrexone (Primary)
  • Indications Opioid abuse
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 May 2017 Planned primary completion date changed from 1 Sep 2018 to 1 Mar 2019.
    • 02 May 2017 Planned initiation date changed from 1 Mar 2017 to 1 Jun 2017.
    • 06 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top